2016-2020 Survey of the Automated Microbiology Market in 33 Countries: Supplier Shares, Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests
This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This comprehensive 33-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Geographic Coverage
Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA
Specimen Types
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia
Technology Review
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R D.
Opportunities and Strategic Recommendations
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This comprehensive 33-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Geographic Coverage
Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA
Specimen Types
- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva
- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Cultures
- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia
Technology Review
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
- Companies developing or marketing microbiology products, by individual test.
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R D.
Opportunities and Strategic Recommendations
- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
1. INTRODUCTION
2. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
3. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
4. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
5. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
6. WORLDWIDE MARKET AND TECHNOLOGY REVIEW
A. DNA Sequencing
1. INTRODUCTION
2. SEQUENCING METHODS
3. AUTORADIOGRAPHY
4. THE HUMAN GENOME PROJECT
5. SEQUENCING AUTOMATION
6. IMAGE SCANNERS
7. FLUORESCENT DETECTION
8. GENE PROFILING
9. GENE EXPRESSION
10. POLYMORPHISM SCREENING
11. PROTEIN INTERACTION NETWORKS
B. DNA and RNA Probe Technologies
1. BASIC PRINCIPLES
2. PROBE PREPARATION
3. THE DNA PROBE TEST
4. TEST FORMATS
5. LABELING TECHNIQUES
6. AMPLIFICATION METHODS
C. Detection Technologies
1. RADIOACTIVE METHODS
a. Overview
b. Major Isotopes
2. NONISOTOPIC METHODS
a. Enzymatic Labels
b. Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. ABBOTT LCX
2. BECKMAN COULTER/BIOMEK FK
3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
4. BD INNOVA
5. BECTON DICKINSON SDA
6. BIOMERIEUX NUCLISENS EASYMAG
7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
8. BIO RAD GENESCOPE
9. CEPHEID GENEXPERT
10. CURETIS UNYVERO
11. GENMARK DX ESENSOR XT 8
12. HOLOGIC/GENROBE PANTHER
13. HOLOGIC/GENROBE TIGRIS/DTS
14. HTG MOLECULAR EDGE
15. LIFE TECHNOLOGIES QUANTSTUDI DX
16. QIAGEN QIASYMPHONY RGQ
17. ROCHE COBAS AMPLICOR
18. ROCHE COBAS TAQMAN
19. ROCHE COBAS TAQMAN
20. ROCHE COBAS TAQMAN AMPLIPREP
21. ROCHE LIGHCYCLER
22. ROCHE COBAS 4800
23. ROCHE COBAS S
24. SIEMENS VERSANT
25. TECAN LS SERIES
E. Biochips: Genosensors, Microarrays, Labs on the Chip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications
1. MICROBIOLOGY/INFECTIOUS DISEASES
a. Overview
b. Major Infectious Diseases
AIDS/HIV
Adenovirus
Aeromonads
Anthrax/Bacillus Anthracis
Arboviruses
Babesiosis
Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
Blastocystis Hominis
Brucella
Campylobacter
Candida
Chagas Disease
Chancroid
Chlamydia
Clostridium Difficile
Coronaviruses
Coxsackieviruses
Creutzfeldt Jakob’s Disease
Cryptosporidium Parvum
Cyclospora Cayetanensis
Cytomegalovirus
Ebola Virus
E. Coli
EchoVirus
Encephalitis
Enteroviruses
Epstein Barr Virus
Giardia Lamblia
Gonorrhea
Granuloma Inguinale
Hantavirus
Helicobacter Pylori
Hepatitis
Herpes Simplex Virus
Human Herpes Virus 6 (HHV 6)
Influenza Viruses
Legionella
Lyme Disease
Lymphogranuloma Venereum (LGV)
Malaria
Measles (Rubeola)
Meningitis
Microsporidium
Mononucleosis
Mumps
Mycoplasma
Papillomaviruses
Parvovirus B19
Pneumonia
Polyomaviruses
Pseudomonas Aeruginosa
Rabies
Respiratory Syncytial Virus (RSV)
Rhinoviruses
Rotavirus
Rubella
Salmonellosis
Septicemia
Shigellosis
Staphylococcus Aureus
Streptococci
Syphilis
Toxoplasmosis
Trichomonas Vaginalis
Tuberculosis
Vibrio
West Nile Virus
Yersina
2. CANCER TESTING
a. Overview
b. Major Cancer Types
Prostate
Lung
Colon and Rectum
Breast
Skin
Uterine
Leukemia
Oral
c. Oncogenes
Abl/abl bcr
AIB1
BCL2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP17
ErbB
HPC1
Nmyc
P40
P51
P53
PIK3CA
PTI1
Ras
Reg
Sis
Src
3. GENETIC DISEASES
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
Achondroplasia
Autosomal Dominant Polycystic Kidney Disease
Cancer
Cosmetogenomics
Cystic Fibrosis
Down's Syndrome
Duchenne and Becker Muscular Dystrophy
Factor V (Leiden)
Factor IX Deficiency
Fragile X Syndrome
Heart Disease
Hemochomatosis
Hemophilia
Huntington's Disease
Maternal Fetal Incompatibility
Multiple Endocrine Neoplasia
Phenylketonuria (PKU)
Polycystic Kidney Disease (PKD)
Prenatal Screening
Retinitis Pigmentosa
Retinoblastoma
Sickle Cell Anemia
Spinal Muscular Atrophy
Vitamin B12 Metabolism
i. Social Issues and Concerns
4. FORENSIC TESTING
a. Overview
b. Multilocus and Single Locus Probes
c. DNA Profile Data Banks
d. Judicial Implementation
e. Major Crime Categories
f. Factors Contributing to the DNA Probe Market Expansion
Technology Availability
Use of Hair as Evidence
g. Wildlife Forensics
5. PATERNITY TESTING/HLA TYPING
6. OTHER APPLICATIONS
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing
1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
2. RNA PROBES
3. TWO DIMENSIONAL ELECTROPHORESIS
4. FLOW CYTOMETRY
7. COUNTRY ANALYSES: VOLUME AND SALES FORECASTS INFECTIOUS DISEASES, GENETIC DISEASES, CANCER, FORENSIC AND PATERNITY TESTING
Australia
Austria
Belgium
Bulgaria
Canada
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Japan
Latvia
Lithuania
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia Table of Contents (continued)
Slovenia
Spain
Sweden
Switzerland
UK
USA
8. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix/Thermo Fisher
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
CellMark Forensics/LabCorp
Cepheid
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Genrobe
Illumina
Kreatech/Leica
Li Cor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
Ortho Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
9. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING INNOVATIVE MOLECULAR DIAGNOSTIC TECHNOLOGIES AND PRODUCTS
2. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
3. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
4. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
5. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
6. WORLDWIDE MARKET AND TECHNOLOGY REVIEW
A. DNA Sequencing
1. INTRODUCTION
2. SEQUENCING METHODS
3. AUTORADIOGRAPHY
4. THE HUMAN GENOME PROJECT
5. SEQUENCING AUTOMATION
6. IMAGE SCANNERS
7. FLUORESCENT DETECTION
8. GENE PROFILING
9. GENE EXPRESSION
10. POLYMORPHISM SCREENING
11. PROTEIN INTERACTION NETWORKS
B. DNA and RNA Probe Technologies
1. BASIC PRINCIPLES
2. PROBE PREPARATION
3. THE DNA PROBE TEST
4. TEST FORMATS
5. LABELING TECHNIQUES
6. AMPLIFICATION METHODS
C. Detection Technologies
1. RADIOACTIVE METHODS
a. Overview
b. Major Isotopes
2. NONISOTOPIC METHODS
a. Enzymatic Labels
b. Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. ABBOTT LCX
2. BECKMAN COULTER/BIOMEK FK
3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
4. BD INNOVA
5. BECTON DICKINSON SDA
6. BIOMERIEUX NUCLISENS EASYMAG
7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
8. BIO RAD GENESCOPE
9. CEPHEID GENEXPERT
10. CURETIS UNYVERO
11. GENMARK DX ESENSOR XT 8
12. HOLOGIC/GENROBE PANTHER
13. HOLOGIC/GENROBE TIGRIS/DTS
14. HTG MOLECULAR EDGE
15. LIFE TECHNOLOGIES QUANTSTUDI DX
16. QIAGEN QIASYMPHONY RGQ
17. ROCHE COBAS AMPLICOR
18. ROCHE COBAS TAQMAN
19. ROCHE COBAS TAQMAN
20. ROCHE COBAS TAQMAN AMPLIPREP
21. ROCHE LIGHCYCLER
22. ROCHE COBAS 4800
23. ROCHE COBAS S
24. SIEMENS VERSANT
25. TECAN LS SERIES
E. Biochips: Genosensors, Microarrays, Labs on the Chip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications
1. MICROBIOLOGY/INFECTIOUS DISEASES
a. Overview
b. Major Infectious Diseases
AIDS/HIV
Adenovirus
Aeromonads
Anthrax/Bacillus Anthracis
Arboviruses
Babesiosis
Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
Blastocystis Hominis
Brucella
Campylobacter
Candida
Chagas Disease
Chancroid
Chlamydia
Clostridium Difficile
Coronaviruses
Coxsackieviruses
Creutzfeldt Jakob’s Disease
Cryptosporidium Parvum
Cyclospora Cayetanensis
Cytomegalovirus
Ebola Virus
E. Coli
EchoVirus
Encephalitis
Enteroviruses
Epstein Barr Virus
Giardia Lamblia
Gonorrhea
Granuloma Inguinale
Hantavirus
Helicobacter Pylori
Hepatitis
Herpes Simplex Virus
Human Herpes Virus 6 (HHV 6)
Influenza Viruses
Legionella
Lyme Disease
Lymphogranuloma Venereum (LGV)
Malaria
Measles (Rubeola)
Meningitis
Microsporidium
Mononucleosis
Mumps
Mycoplasma
Papillomaviruses
Parvovirus B19
Pneumonia
Polyomaviruses
Pseudomonas Aeruginosa
Rabies
Respiratory Syncytial Virus (RSV)
Rhinoviruses
Rotavirus
Rubella
Salmonellosis
Septicemia
Shigellosis
Staphylococcus Aureus
Streptococci
Syphilis
Toxoplasmosis
Trichomonas Vaginalis
Tuberculosis
Vibrio
West Nile Virus
Yersina
2. CANCER TESTING
a. Overview
b. Major Cancer Types
Prostate
Lung
Colon and Rectum
Breast
Skin
Uterine
Leukemia
Oral
c. Oncogenes
Abl/abl bcr
AIB1
BCL2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP17
ErbB
HPC1
Nmyc
P40
P51
P53
PIK3CA
PTI1
Ras
Reg
Sis
Src
3. GENETIC DISEASES
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
Achondroplasia
Autosomal Dominant Polycystic Kidney Disease
Cancer
Cosmetogenomics
Cystic Fibrosis
Down's Syndrome
Duchenne and Becker Muscular Dystrophy
Factor V (Leiden)
Factor IX Deficiency
Fragile X Syndrome
Heart Disease
Hemochomatosis
Hemophilia
Huntington's Disease
Maternal Fetal Incompatibility
Multiple Endocrine Neoplasia
Phenylketonuria (PKU)
Polycystic Kidney Disease (PKD)
Prenatal Screening
Retinitis Pigmentosa
Retinoblastoma
Sickle Cell Anemia
Spinal Muscular Atrophy
Vitamin B12 Metabolism
i. Social Issues and Concerns
4. FORENSIC TESTING
a. Overview
b. Multilocus and Single Locus Probes
c. DNA Profile Data Banks
d. Judicial Implementation
e. Major Crime Categories
f. Factors Contributing to the DNA Probe Market Expansion
Technology Availability
Use of Hair as Evidence
g. Wildlife Forensics
5. PATERNITY TESTING/HLA TYPING
6. OTHER APPLICATIONS
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing
1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
2. RNA PROBES
3. TWO DIMENSIONAL ELECTROPHORESIS
4. FLOW CYTOMETRY
7. COUNTRY ANALYSES: VOLUME AND SALES FORECASTS INFECTIOUS DISEASES, GENETIC DISEASES, CANCER, FORENSIC AND PATERNITY TESTING
Australia
Austria
Belgium
Bulgaria
Canada
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Japan
Latvia
Lithuania
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia Table of Contents (continued)
Slovenia
Spain
Sweden
Switzerland
UK
USA
8. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix/Thermo Fisher
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
CellMark Forensics/LabCorp
Cepheid
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Genrobe
Illumina
Kreatech/Leica
Li Cor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
Ortho Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
9. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING INNOVATIVE MOLECULAR DIAGNOSTIC TECHNOLOGIES AND PRODUCTS
LIST OF TABLES
Australia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Australia Molecular Diagnostics Test Volume Forecasts by Application
Australia Major Infectious Disease Test Volume Forecasts by Assay
Australia Molecular Diagnostics Market Forecasts by Application
Australia Major Infectious Disease Diagnostics Market Forecasts by Assay
Austria Molecular Diagnostics Test Volume and Sales Forecasts by Application
Austria Molecular Diagnostics Test Volume Forecasts by Application
Austria Major Infectious Disease Test Volume Forecasts by Assay
Austria Molecular Diagnostics Market Forecasts by Application
Austria Major Infectious Disease Diagnostics Market Forecasts by Assay
Belgium Molecular Diagnostics Test Volume and Sales Forecasts by Application
Belgium Molecular Diagnostics Test Volume Forecasts by Application
Belgium Major Infectious Disease Test Volume Forecasts by Assay
Belgium Molecular Diagnostics Market Forecasts by Application
Belgium Major Infectious Disease Diagnostics Market Forecasts by Assay
Bulgaria Molecular Diagnostics Test Volume and Sales Forecasts by Application
Bulgaria Molecular Diagnostics Test Volume Forecasts by Application
Bulgaria Major Infectious Disease Test Volume Forecasts by Assay
Bulgaria Molecular Diagnostics Market Forecasts by Application
Bulgaria Major Infectious Disease Diagnostics Market Forecasts by Assay
Canada Molecular Diagnostics Test Volume and Sales Forecasts by Application
Canada Molecular Diagnostics Test Volume Forecasts by Application
Canada Major Infectious Disease Test Volume Forecasts by Assay
Canada Molecular Diagnostics Market Forecasts by Application
Canada Major Infectious Disease Diagnostics Market Forecasts by Assay
Cyprus Molecular Diagnostics Test Volume and Sales Forecasts by Application
Cyprus Molecular Diagnostics Test Volume Forecasts by Application
Cyprus Major Infectious Disease Test Volume Forecasts by Assay
Cyprus Molecular Diagnostics Market Forecasts by Application
Cyprus Major Infectious Disease Diagnostics Market Forecasts by Assay
Czech Republic Molecular Diagnostics Test Volume and Sales Forecasts by Application
Czech Republic Molecular Diagnostics Test Volume Forecasts by Application
Czech Republic Major Infectious Disease Test Volume Forecasts by Assay
Czech Republic Molecular Diagnostics Market Forecasts by Application
Czech Republic Major Infectious Disease Diagnostics Market Forecasts by Assay
Denmark Molecular Diagnostics Test Volume and Sales Forecasts by Application
Denmark Molecular Diagnostics Test Volume Forecasts by Application
Denmark Major Infectious Disease Test Volume Forecasts by Assay
Denmark Molecular Diagnostics Market Forecasts by Application
Denmark Major Infectious Disease Diagnostics Market Forecasts by Assay
Estonia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Estonia Molecular Diagnostics Test Volume Forecasts by Application
Estonia Major Infectious Disease Test Volume Forecasts by Assay
Estonia Molecular Diagnostics Market Forecasts by Application
Estonia Major Infectious Disease Diagnostics Market Forecasts by Assay
Finland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Finland Molecular Diagnostics Test Volume Forecasts by Application
Finland Major Infectious Disease Test Volume Forecasts by Assay
Finland Molecular Diagnostics Market Forecasts by Application
Finland Major Infectious Disease Diagnostics Market Forecasts by Assay
France Molecular Diagnostics Test Volume and Sales by Major Application
France Laboratories Performing DNA Sequencing by Market Segment
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France Molecular Diagnostics Test Volume by Major Application
France Major Infectious Disease Test Volume by Assay
France Major Infectious Disease Test Volume by Method
France Molecular Diagnostics Market by Major Application
France Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
France Major Infectious Disease Diagnostics Market by Assay
France AIDS Testing Market Estimated Sales by Major Supplier
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplier
Germany Molecular Diagnostics Test Volume and Sales by Major Application
Germany Laboratories Performing DNA Sequencing by Market Segment
Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany Molecular Diagnostics Test Volume by Major Application
Germany Major Infectious Disease Test Volume by Assay
Germany Major Infectious Disease Test Volume by Method
Germany Molecular Diagnostics Market by Major Application
Germany Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Germany Major Infectious Disease Diagnostics Market by Assay
Germany AIDS Testing Market Estimated Sales by Major Supplier
Germany CMV Testing Market Estimated Sales by Major Supplier
Germany EBV Testing Market Estimated Sales by Major Supplier
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany Hepatitis Testing Market Estimated Sales by Major Supplier
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany Herpes Testing Market Estimated Sales by Major Supplier
Germany Influenza Testing Market Estimated Sales by Major Supplier
Germany Meningitis Testing Market Estimated Sales by Major Supplier
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany Pneumonia Testing Market Estimated Sales by Major Supplier
Germany RSV Testing Market Estimated Sales by Major Supplier
Germany Rotavirus Testing Market Estimated Sales by Major Supplier
Greece Molecular Diagnostics Test Volume and Sales Forecasts by Application
Greece Molecular Diagnostics Test Volume Forecasts by Application
Greece Major Infectious Disease Test Volume Forecasts by Assay
Greece Molecular Diagnostics Market Forecasts by Application
Greece Major Infectious Disease Diagnostics Market Forecasts by Assay
Hungary Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hungary Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hungary Molecular Diagnostics Test Volume Forecasts by Application
Hungary Major Infectious Disease Test Volume Forecasts by Assay
Hungary Molecular Diagnostics Market Forecasts by Application
Hungary Major Infectious Disease Diagnostics Market Forecasts by Assay
Iceland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Iceland Molecular Diagnostics Test Volume Forecasts by Application
Iceland Major Infectious Disease Test Volume Forecasts by Assay
Iceland Molecular Diagnostics Market Forecasts by Application
Iceland Major Infectious Disease Diagnostics Market Forecasts by Assay
Ireland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Ireland Molecular Diagnostics Test Volume Forecasts by Application
Ireland Major Infectious Disease Test Volume Forecasts by Assay
Ireland Molecular Diagnostics Market Forecasts by Application
Ireland Major Infectious Disease Diagnostics Market Forecasts by Assay
Italy Molecular Diagnostics Test Volume and Sales by Major Application
Italy Laboratories Performing DNA Sequencing by Market Segment
Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy Molecular Diagnostics Test Volume by Major Application
Italy Major Infectious Disease Test Volume by Assay
Italy Major Infectious Disease Test Volume by Method
Italy Molecular Diagnostics Market by Major Application
Italy Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Italy Major Infectious Disease Diagnostics Market by Assay
Italy AIDS Testing Market Estimated Sales by Major Supplier
Italy CMV Testing Market Estimated Sales by Major Supplier
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy Hepatitis Testing Market Estimated Sales by Major Supplier
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy Herpes Testing Market Estimated Sales by Major Supplier
Italy Influenza Testing Market Estimated Sales by Major Supplier
Italy Meningitis Testing Market Estimated Sales by Major Supplier
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy RSV Testing Market Estimated Sales by Major Supplier
Japan Molecular Diagnostics Test Volume and Sales by Major Application
Japan Laboratories Performing DNA Sequencing by Market Segment
Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan Molecular Diagnostics Test Volume by Major Application
Japan Major Infectious Disease Test Volume by Assay
Japan Major Infectious Disease Test Volume by Method
Japan Molecular Diagnostics Market by Major Application
Japan Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Japan Major Infectious Disease Diagnostics Market by Assay
Japan AIDS Testing Market Estimated Sales by Major Supplier
Japan Chlamydia Testing Market Estimated Sales by Major Supplier
Japan CMV Testing Market Estimated Sales by Major Supplier
Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan Hepatitis Testing Market Estimated Sales by Major Supplier
Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan Herpes Testing Market Estimated Sales by Major Supplier
Japan Meningitis Testing Market Estimated Sales by Major Supplier
Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan Pneumonia Testing Market Estimated Sales by Major Supplier
Japan Shigella Testing Market Estimated Sales by Major Supplier
Latvia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Latvia Molecular Diagnostics Test Volume Forecasts by Application
Latvia Major Infectious Disease Test Volume Forecasts by Assay
Latvia Molecular Diagnostics Market Forecasts by Application
Latvia Major Infectious Disease Diagnostics Market Forecasts by Assay
Lithuania Molecular Diagnostics Test Volume and Sales Forecasts by Application
Lithuania Molecular Diagnostics Test Volume Forecasts by Application
Lithuania Major Infectious Disease Test Volume Forecasts by Assay
Lithuania Molecular Diagnostics Market Forecasts by Application
Lithuania Major Infectious Disease Diagnostics Market Forecasts by Assay
Malta Molecular Diagnostics Test Volume and Sales Forecasts by Application
Malta Molecular Diagnostics Test Volume Forecasts by Application
Malta Major Infectious Disease Test Volume Forecasts by Assay
Malta Molecular Diagnostics Market Forecasts by Application
Malta Major Infectious Disease Diagnostics Market Forecasts by Assay
Netherlands Molecular Diagnostics Test Volume and Sales Forecasts by Application
Netherlands Molecular Diagnostics Test Volume Forecasts by Application
Netherlands Major Infectious Disease Test Volume Forecasts by Assay
Netherlands Molecular Diagnostics Market Forecasts by Application
Netherlands Major Infectious Disease Diagnostics Market Forecasts by Assay
Norway Molecular Diagnostics Test Volume and Sales Forecasts by Application
Norway Molecular Diagnostics Test Volume Forecasts by Application
Norway Major Infectious Disease Test Volume Forecasts by Assay
Norway Molecular Diagnostics Market Forecasts by Application
Norway Major Infectious Disease Diagnostics Market Forecasts by Assay
Poland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Poland Molecular Diagnostics Test Volume Forecasts by Application
Poland Major Infectious Disease Test Volume Forecasts by Assay
Poland Molecular Diagnostics Market Forecasts by Application
Poland Major Infectious Disease Diagnostics Market Forecasts by Assay
Portugal Molecular Diagnostics Test Volume and Sales Forecasts by Application
Portugal Molecular Diagnostics Test Volume Forecasts by Application
Portugal Major Infectious Disease Test Volume Forecasts by Assay
Portugal Major Infectious Disease Diagnostics Market Forecasts by Assay
Romania Molecular Diagnostics Test Volume and Sales Forecasts by Application
Romania Molecular Diagnostics Test Volume Forecasts by Application
Romania Major Infectious Disease Test Volume Forecasts by Assay
Romania Molecular Diagnostics Market Forecasts by Application
Romania Major Infectious Disease Diagnostics Market Forecasts by Assay
Slovakia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Slovakia Molecular Diagnostics Test Volume Forecasts by Application
Slovakia Major Infectious Disease Test Volume Forecasts by Assay
Slovakia Molecular Diagnostics Market Forecasts by Application
Slovakia Major Infectious Disease Diagnostics Market Forecasts by Assay
Slovenia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Slovenia Molecular Diagnostics Test Volume Forecasts by Application
Slovenia Major Infectious Disease Test Volume Forecasts by Assay
Slovenia Molecular Diagnostics Market Forecasts by Application
Slovenia Major Infectious Disease Diagnostics Market Forecasts by Assay
Spain Molecular Diagnostics Test Volume and Sales by Major Application
Spain Laboratories Performing DNA Sequencing by Market Segment
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain Molecular Diagnostics Test Volume by Major Application
Spain Major Infectious Disease Test Volume by Assay
Spain Major Infectious Disease Test Volume by Method
Spain Molecular Diagnostics Market by Major Application
Spain Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Spain Major Infectious Disease Diagnostics Market by Assay
Spain AIDS Testing Market Estimated Sales by Major Supplier
Spain Chlamydia Testing Market Estimated Sales by Major Supplier
Spain CMV Testing Market Estimated Sales by Major Supplier
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain Hepatitis Testing Market Estimated Sales by Major Supplier
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain Herpes Testing Market Estimated Sales by Major Supplier
Spain Influenza Testing Market Estimated Sales by Major Supplier
Spain Meningitis Testing Market Estimated Sales by Major Supplier
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
Sweden Molecular Diagnostics Test Volume and Sales Forecasts by Application
Sweden Molecular Diagnostics Test Volume Forecasts by Application
Sweden Major Infectious Disease Test Volume Forecasts by Assay
Sweden Molecular Diagnostics Market Forecasts by Application
Sweden Major Infectious Disease Diagnostics Market Forecasts by Assay
Switzerland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Switzerland Molecular Diagnostics Test Volume Forecasts by Application
Switzerland Major Infectious Disease Test Volume Forecasts by Assay
Switzerland Molecular Diagnostics Market Forecasts by Application
Switzerland Major Infectious Disease Diagnostics Market Forecasts by Assay
U.K. Molecular Diagnostics Test Volume and Sales by Major Application
U.K. Laboratories Performing DNA Sequencing by Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume by Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market by Major Application
U.K. Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A. Laboratories Performing DNA Sequencing by Market Segment
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A. Laboratories Performing DNA Sequencing by Market Segment
U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A. EBV Testing Market Estimated Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
U.S.A. RSV Testing Market Estimated Sales by Major Supplier
U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests for Genetic Diseases
Australia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Australia Molecular Diagnostics Test Volume Forecasts by Application
Australia Major Infectious Disease Test Volume Forecasts by Assay
Australia Molecular Diagnostics Market Forecasts by Application
Australia Major Infectious Disease Diagnostics Market Forecasts by Assay
Austria Molecular Diagnostics Test Volume and Sales Forecasts by Application
Austria Molecular Diagnostics Test Volume Forecasts by Application
Austria Major Infectious Disease Test Volume Forecasts by Assay
Austria Molecular Diagnostics Market Forecasts by Application
Austria Major Infectious Disease Diagnostics Market Forecasts by Assay
Belgium Molecular Diagnostics Test Volume and Sales Forecasts by Application
Belgium Molecular Diagnostics Test Volume Forecasts by Application
Belgium Major Infectious Disease Test Volume Forecasts by Assay
Belgium Molecular Diagnostics Market Forecasts by Application
Belgium Major Infectious Disease Diagnostics Market Forecasts by Assay
Bulgaria Molecular Diagnostics Test Volume and Sales Forecasts by Application
Bulgaria Molecular Diagnostics Test Volume Forecasts by Application
Bulgaria Major Infectious Disease Test Volume Forecasts by Assay
Bulgaria Molecular Diagnostics Market Forecasts by Application
Bulgaria Major Infectious Disease Diagnostics Market Forecasts by Assay
Canada Molecular Diagnostics Test Volume and Sales Forecasts by Application
Canada Molecular Diagnostics Test Volume Forecasts by Application
Canada Major Infectious Disease Test Volume Forecasts by Assay
Canada Molecular Diagnostics Market Forecasts by Application
Canada Major Infectious Disease Diagnostics Market Forecasts by Assay
Cyprus Molecular Diagnostics Test Volume and Sales Forecasts by Application
Cyprus Molecular Diagnostics Test Volume Forecasts by Application
Cyprus Major Infectious Disease Test Volume Forecasts by Assay
Cyprus Molecular Diagnostics Market Forecasts by Application
Cyprus Major Infectious Disease Diagnostics Market Forecasts by Assay
Czech Republic Molecular Diagnostics Test Volume and Sales Forecasts by Application
Czech Republic Molecular Diagnostics Test Volume Forecasts by Application
Czech Republic Major Infectious Disease Test Volume Forecasts by Assay
Czech Republic Molecular Diagnostics Market Forecasts by Application
Czech Republic Major Infectious Disease Diagnostics Market Forecasts by Assay
Denmark Molecular Diagnostics Test Volume and Sales Forecasts by Application
Denmark Molecular Diagnostics Test Volume Forecasts by Application
Denmark Major Infectious Disease Test Volume Forecasts by Assay
Denmark Molecular Diagnostics Market Forecasts by Application
Denmark Major Infectious Disease Diagnostics Market Forecasts by Assay
Estonia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Estonia Molecular Diagnostics Test Volume Forecasts by Application
Estonia Major Infectious Disease Test Volume Forecasts by Assay
Estonia Molecular Diagnostics Market Forecasts by Application
Estonia Major Infectious Disease Diagnostics Market Forecasts by Assay
Finland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Finland Molecular Diagnostics Test Volume Forecasts by Application
Finland Major Infectious Disease Test Volume Forecasts by Assay
Finland Molecular Diagnostics Market Forecasts by Application
Finland Major Infectious Disease Diagnostics Market Forecasts by Assay
France Molecular Diagnostics Test Volume and Sales by Major Application
France Laboratories Performing DNA Sequencing by Market Segment
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France Molecular Diagnostics Test Volume by Major Application
France Major Infectious Disease Test Volume by Assay
France Major Infectious Disease Test Volume by Method
France Molecular Diagnostics Market by Major Application
France Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
France Major Infectious Disease Diagnostics Market by Assay
France AIDS Testing Market Estimated Sales by Major Supplier
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplier
Germany Molecular Diagnostics Test Volume and Sales by Major Application
Germany Laboratories Performing DNA Sequencing by Market Segment
Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany Molecular Diagnostics Test Volume by Major Application
Germany Major Infectious Disease Test Volume by Assay
Germany Major Infectious Disease Test Volume by Method
Germany Molecular Diagnostics Market by Major Application
Germany Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Germany Major Infectious Disease Diagnostics Market by Assay
Germany AIDS Testing Market Estimated Sales by Major Supplier
Germany CMV Testing Market Estimated Sales by Major Supplier
Germany EBV Testing Market Estimated Sales by Major Supplier
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany Hepatitis Testing Market Estimated Sales by Major Supplier
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany Herpes Testing Market Estimated Sales by Major Supplier
Germany Influenza Testing Market Estimated Sales by Major Supplier
Germany Meningitis Testing Market Estimated Sales by Major Supplier
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany Pneumonia Testing Market Estimated Sales by Major Supplier
Germany RSV Testing Market Estimated Sales by Major Supplier
Germany Rotavirus Testing Market Estimated Sales by Major Supplier
Greece Molecular Diagnostics Test Volume and Sales Forecasts by Application
Greece Molecular Diagnostics Test Volume Forecasts by Application
Greece Major Infectious Disease Test Volume Forecasts by Assay
Greece Molecular Diagnostics Market Forecasts by Application
Greece Major Infectious Disease Diagnostics Market Forecasts by Assay
Hungary Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hungary Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hungary Molecular Diagnostics Test Volume Forecasts by Application
Hungary Major Infectious Disease Test Volume Forecasts by Assay
Hungary Molecular Diagnostics Market Forecasts by Application
Hungary Major Infectious Disease Diagnostics Market Forecasts by Assay
Iceland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Iceland Molecular Diagnostics Test Volume Forecasts by Application
Iceland Major Infectious Disease Test Volume Forecasts by Assay
Iceland Molecular Diagnostics Market Forecasts by Application
Iceland Major Infectious Disease Diagnostics Market Forecasts by Assay
Ireland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Ireland Molecular Diagnostics Test Volume Forecasts by Application
Ireland Major Infectious Disease Test Volume Forecasts by Assay
Ireland Molecular Diagnostics Market Forecasts by Application
Ireland Major Infectious Disease Diagnostics Market Forecasts by Assay
Italy Molecular Diagnostics Test Volume and Sales by Major Application
Italy Laboratories Performing DNA Sequencing by Market Segment
Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy Molecular Diagnostics Test Volume by Major Application
Italy Major Infectious Disease Test Volume by Assay
Italy Major Infectious Disease Test Volume by Method
Italy Molecular Diagnostics Market by Major Application
Italy Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Italy Major Infectious Disease Diagnostics Market by Assay
Italy AIDS Testing Market Estimated Sales by Major Supplier
Italy CMV Testing Market Estimated Sales by Major Supplier
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy Hepatitis Testing Market Estimated Sales by Major Supplier
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy Herpes Testing Market Estimated Sales by Major Supplier
Italy Influenza Testing Market Estimated Sales by Major Supplier
Italy Meningitis Testing Market Estimated Sales by Major Supplier
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy RSV Testing Market Estimated Sales by Major Supplier
Japan Molecular Diagnostics Test Volume and Sales by Major Application
Japan Laboratories Performing DNA Sequencing by Market Segment
Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan Molecular Diagnostics Test Volume by Major Application
Japan Major Infectious Disease Test Volume by Assay
Japan Major Infectious Disease Test Volume by Method
Japan Molecular Diagnostics Market by Major Application
Japan Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Japan Major Infectious Disease Diagnostics Market by Assay
Japan AIDS Testing Market Estimated Sales by Major Supplier
Japan Chlamydia Testing Market Estimated Sales by Major Supplier
Japan CMV Testing Market Estimated Sales by Major Supplier
Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan Hepatitis Testing Market Estimated Sales by Major Supplier
Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan Herpes Testing Market Estimated Sales by Major Supplier
Japan Meningitis Testing Market Estimated Sales by Major Supplier
Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan Pneumonia Testing Market Estimated Sales by Major Supplier
Japan Shigella Testing Market Estimated Sales by Major Supplier
Latvia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Latvia Molecular Diagnostics Test Volume Forecasts by Application
Latvia Major Infectious Disease Test Volume Forecasts by Assay
Latvia Molecular Diagnostics Market Forecasts by Application
Latvia Major Infectious Disease Diagnostics Market Forecasts by Assay
Lithuania Molecular Diagnostics Test Volume and Sales Forecasts by Application
Lithuania Molecular Diagnostics Test Volume Forecasts by Application
Lithuania Major Infectious Disease Test Volume Forecasts by Assay
Lithuania Molecular Diagnostics Market Forecasts by Application
Lithuania Major Infectious Disease Diagnostics Market Forecasts by Assay
Malta Molecular Diagnostics Test Volume and Sales Forecasts by Application
Malta Molecular Diagnostics Test Volume Forecasts by Application
Malta Major Infectious Disease Test Volume Forecasts by Assay
Malta Molecular Diagnostics Market Forecasts by Application
Malta Major Infectious Disease Diagnostics Market Forecasts by Assay
Netherlands Molecular Diagnostics Test Volume and Sales Forecasts by Application
Netherlands Molecular Diagnostics Test Volume Forecasts by Application
Netherlands Major Infectious Disease Test Volume Forecasts by Assay
Netherlands Molecular Diagnostics Market Forecasts by Application
Netherlands Major Infectious Disease Diagnostics Market Forecasts by Assay
Norway Molecular Diagnostics Test Volume and Sales Forecasts by Application
Norway Molecular Diagnostics Test Volume Forecasts by Application
Norway Major Infectious Disease Test Volume Forecasts by Assay
Norway Molecular Diagnostics Market Forecasts by Application
Norway Major Infectious Disease Diagnostics Market Forecasts by Assay
Poland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Poland Molecular Diagnostics Test Volume Forecasts by Application
Poland Major Infectious Disease Test Volume Forecasts by Assay
Poland Molecular Diagnostics Market Forecasts by Application
Poland Major Infectious Disease Diagnostics Market Forecasts by Assay
Portugal Molecular Diagnostics Test Volume and Sales Forecasts by Application
Portugal Molecular Diagnostics Test Volume Forecasts by Application
Portugal Major Infectious Disease Test Volume Forecasts by Assay
Portugal Major Infectious Disease Diagnostics Market Forecasts by Assay
Romania Molecular Diagnostics Test Volume and Sales Forecasts by Application
Romania Molecular Diagnostics Test Volume Forecasts by Application
Romania Major Infectious Disease Test Volume Forecasts by Assay
Romania Molecular Diagnostics Market Forecasts by Application
Romania Major Infectious Disease Diagnostics Market Forecasts by Assay
Slovakia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Slovakia Molecular Diagnostics Test Volume Forecasts by Application
Slovakia Major Infectious Disease Test Volume Forecasts by Assay
Slovakia Molecular Diagnostics Market Forecasts by Application
Slovakia Major Infectious Disease Diagnostics Market Forecasts by Assay
Slovenia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Slovenia Molecular Diagnostics Test Volume Forecasts by Application
Slovenia Major Infectious Disease Test Volume Forecasts by Assay
Slovenia Molecular Diagnostics Market Forecasts by Application
Slovenia Major Infectious Disease Diagnostics Market Forecasts by Assay
Spain Molecular Diagnostics Test Volume and Sales by Major Application
Spain Laboratories Performing DNA Sequencing by Market Segment
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain Molecular Diagnostics Test Volume by Major Application
Spain Major Infectious Disease Test Volume by Assay
Spain Major Infectious Disease Test Volume by Method
Spain Molecular Diagnostics Market by Major Application
Spain Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Spain Major Infectious Disease Diagnostics Market by Assay
Spain AIDS Testing Market Estimated Sales by Major Supplier
Spain Chlamydia Testing Market Estimated Sales by Major Supplier
Spain CMV Testing Market Estimated Sales by Major Supplier
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain Hepatitis Testing Market Estimated Sales by Major Supplier
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain Herpes Testing Market Estimated Sales by Major Supplier
Spain Influenza Testing Market Estimated Sales by Major Supplier
Spain Meningitis Testing Market Estimated Sales by Major Supplier
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
Sweden Molecular Diagnostics Test Volume and Sales Forecasts by Application
Sweden Molecular Diagnostics Test Volume Forecasts by Application
Sweden Major Infectious Disease Test Volume Forecasts by Assay
Sweden Molecular Diagnostics Market Forecasts by Application
Sweden Major Infectious Disease Diagnostics Market Forecasts by Assay
Switzerland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Switzerland Molecular Diagnostics Test Volume Forecasts by Application
Switzerland Major Infectious Disease Test Volume Forecasts by Assay
Switzerland Molecular Diagnostics Market Forecasts by Application
Switzerland Major Infectious Disease Diagnostics Market Forecasts by Assay
U.K. Molecular Diagnostics Test Volume and Sales by Major Application
U.K. Laboratories Performing DNA Sequencing by Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume by Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market by Major Application
U.K. Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A. Laboratories Performing DNA Sequencing by Market Segment
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A. Laboratories Performing DNA Sequencing by Market Segment
U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A. EBV Testing Market Estimated Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
U.S.A. RSV Testing Market Estimated Sales by Major Supplier
U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests for Genetic Diseases